《大行報告》大摩下調安踏(02020.HK)目標價至185元 評級「增持」
摩根士丹利發表報告,將安踏體育(02020.HK)2021年、2022年和2023年的營業額預測分別下調4%、5%和6%,並將盈利預期分別下調7%、9%和11%,以反映由於疫情反覆和內地今年下半年宏觀經濟放緩而導致的行業需求減弱。
該行表示,下調安踏目標價由203元至185元,目標市盈率維持在2022年的40倍,維持「增持」評級。
大摩指保守地預測,第三季度安踏的零售銷售增長為10%,料旗下FILA的零售銷售增長為高個位數至10%。第四季度的趨勢只是輕微高於第三季度。全年計,該行預測安踏和FILA的零售銷售增長分別為22%和30%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.